These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22038266)

  • 1. Anti-PF4/heparin antibodies are associated with arteriovenous fistula thrombosis in non-diabetic hemodialysis patients.
    Tsai YF; Chen CA; Kuo C; Lin KC
    Clin Exp Nephrol; 2012 Apr; 16(2):300-5. PubMed ID: 22038266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-platelet factor 4/heparin antibody is associated with progression of peripheral arterial disease in hemodialysis patients.
    Chen YH; Lin KC; Tsai YF; Yu LK; Huang LH; Chen CA
    Int Urol Nephrol; 2015 Sep; 47(9):1565-70. PubMed ID: 26198856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
    Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
    Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant association of anti-platelet factor 4/heparin antibody with cardiovascular disease in hemodialysis patients: a longitudinal 7-year study.
    Liu CC; Chou LP; Chen TS; Chen CA; Tsai YF
    Int Urol Nephrol; 2018 Dec; 50(12):2289-2297. PubMed ID: 30324576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia.
    Matsuo T; Wanaka K; Walenga JM
    Clin Appl Thromb Hemost; 2013; 19(1):73-8. PubMed ID: 22345486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
    Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
    J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
    Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
    Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
    Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
    J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation.
    Bakchoul T; Assfalg V; Zöllner H; Evert M; Novotny A; Matevossian E; Friess H; Hartmann D; Hron G; Althaus K; Greinacher A; Hüser N
    J Thromb Haemost; 2014 Jun; 12(6):871-8. PubMed ID: 24655935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels.
    Baroletti S; Hurwitz S; Conti NA; Fanikos J; Piazza G; Goldhaber SZ
    Am J Med; 2012 Jan; 125(1):44-9. PubMed ID: 22075045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients.
    Matsuo T; Wanaka K; Miyasita K; Prechel M; Walenga JM
    Thromb Res; 2012 Apr; 129(4):474-8. PubMed ID: 22088491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of anti-heparin-platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis.
    O'Shea SI; Sands JJ; Nudo SA; Ortel TL
    Am J Hematol; 2002 Jan; 69(1):72-3. PubMed ID: 11835336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis.
    Warkentin TE; Sheppard JI; Sun JC; Jung H; Eikelboom JW
    J Thromb Haemost; 2013 Feb; 11(2):253-60. PubMed ID: 23216710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
    Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
    J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.
    Kasthuri RS; Glover SL; Jonas W; McEachron T; Pawlinski R; Arepally GM; Key NS; Mackman N
    Blood; 2012 May; 119(22):5285-93. PubMed ID: 22394597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
    Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
    J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
    Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
    Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
    Nazy I; Clare R; Staibano P; Warkentin TE; Larché M; Moore JC; Smith JW; Whitlock RP; Kelton JG; Arnold DM
    J Thromb Haemost; 2018 Jul; 16(7):1402-1412. PubMed ID: 29723924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis.
    Palomo I; Pereira J; Alarcón M; Díaz G; Hidalgo P; Pizarro I; Jara E; Rojas P; Quiroga G; Moore-Carrasco R
    J Clin Lab Anal; 2005; 19(5):189-95. PubMed ID: 16170812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.